Articles about parkinson's

Biotech startup developing tests and treatments for Alzheimer’s and Parkinson’s disease raises $52.9M

University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million… Read More

UW team imagines a better Parkinson’s test, lands in global finals for Microsoft student competition

A team of students from the University of Washington is among the global finalists in Microsoft’s annual Imagine Cup after… Read More

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity

Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central… Read More

parkinson’s

Biotech startup developing tests and treatments for Alzheimer’s and Parkinson’s disease raises $52.9M

UW team imagines a better Parkinson’s test, lands in global finals for Microsoft student competition

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity